| Renjy Vattasseril, MD | |
|
217 N Main St, Suite 102, Cape May Court House, NJ 08210-2165 | |
| (609) 536-8010 | |
| (609) 536-8053 |
| Full Name | Renjy Vattasseril |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 22 Years |
| Location | 217 N Main St, Cape May Court House, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093748089 | NPI | - | NPPES |
| P01227607 | Other | NJ | RAILROAD MEDICARE |
| 0232475 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 239444 (New York) | Secondary |
| 207RG0100X | Internal Medicine - Gastroenterology | 25MA08709900 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cape Regional Medical Center Inc | Cape may court house, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cape Physicians Associates Pa | 0749333730 | 97 |
News Archive
A research team led by Gaya Amarasinghe, an assistant professor of biochemistry, biophysics and molecular biology, had previously solved the structure of a critical part of an Ebola protein known as VP35, which is involved in host immune suppression.
Precision Antibody announced today its selection by Science Applications International Corporation-Frederick to provide antibody and antigen characterization, including surface plasmon resonance analysis, for the National Cancer Institute's "Clinical Proteomic Technologies for Cancer" initiative. A goal of the CPTC is to develop a standardized resource of very high-quality, renewable reference antibodies generated against cancer-related proteins. The antibodies will be made available to proteomics researchers, along with characterization data and other information intended to support replication and standardization.
Awareness of the influence of our genetic variation to dietary response (nutrigenetics) and how nutrients may affect gene expression (nutrigenomics) is prompting a revolution in the field of nutrition. Nutrigenetics/Nutrigenomics provide powerful approaches to unravel the complex relationships among nutritional molecules, genetic variants and the biological system.
Nektar Therapeutics announced today that positive data from the first single-ascending dose Phase 1a clinical study of NKTR-192, the company's novel short-acting mu-opioid analgesic candidate, demonstrate that the drug candidate achieved its target pharmacokinetic profile.
BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.
› Verified 1 days ago
| Entity Name | Cape Physicians Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003805227 PECOS PAC ID: 0749333730 Enrollment ID: O20090928000078 |
News Archive
A research team led by Gaya Amarasinghe, an assistant professor of biochemistry, biophysics and molecular biology, had previously solved the structure of a critical part of an Ebola protein known as VP35, which is involved in host immune suppression.
Precision Antibody announced today its selection by Science Applications International Corporation-Frederick to provide antibody and antigen characterization, including surface plasmon resonance analysis, for the National Cancer Institute's "Clinical Proteomic Technologies for Cancer" initiative. A goal of the CPTC is to develop a standardized resource of very high-quality, renewable reference antibodies generated against cancer-related proteins. The antibodies will be made available to proteomics researchers, along with characterization data and other information intended to support replication and standardization.
Awareness of the influence of our genetic variation to dietary response (nutrigenetics) and how nutrients may affect gene expression (nutrigenomics) is prompting a revolution in the field of nutrition. Nutrigenetics/Nutrigenomics provide powerful approaches to unravel the complex relationships among nutritional molecules, genetic variants and the biological system.
Nektar Therapeutics announced today that positive data from the first single-ascending dose Phase 1a clinical study of NKTR-192, the company's novel short-acting mu-opioid analgesic candidate, demonstrate that the drug candidate achieved its target pharmacokinetic profile.
BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Renjy Vattasseril, MD Po Box 593, Cape May Court House, NJ 08210-0593 Ph: (609) 463-2755 | Renjy Vattasseril, MD 217 N Main St, Suite 102, Cape May Court House, NJ 08210-2165 Ph: (609) 536-8010 |
News Archive
A research team led by Gaya Amarasinghe, an assistant professor of biochemistry, biophysics and molecular biology, had previously solved the structure of a critical part of an Ebola protein known as VP35, which is involved in host immune suppression.
Precision Antibody announced today its selection by Science Applications International Corporation-Frederick to provide antibody and antigen characterization, including surface plasmon resonance analysis, for the National Cancer Institute's "Clinical Proteomic Technologies for Cancer" initiative. A goal of the CPTC is to develop a standardized resource of very high-quality, renewable reference antibodies generated against cancer-related proteins. The antibodies will be made available to proteomics researchers, along with characterization data and other information intended to support replication and standardization.
Awareness of the influence of our genetic variation to dietary response (nutrigenetics) and how nutrients may affect gene expression (nutrigenomics) is prompting a revolution in the field of nutrition. Nutrigenetics/Nutrigenomics provide powerful approaches to unravel the complex relationships among nutritional molecules, genetic variants and the biological system.
Nektar Therapeutics announced today that positive data from the first single-ascending dose Phase 1a clinical study of NKTR-192, the company's novel short-acting mu-opioid analgesic candidate, demonstrate that the drug candidate achieved its target pharmacokinetic profile.
BioMimetic Therapeutics, Inc. today announced its schedule of events at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting being held at the Gaylord National Hotel and Convention Center in National Harbor, Maryland from July 7 - 10, 2010.
› Verified 1 days ago
Dr. Christopher G Zitnay, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 2 Stone Harbor Blvd, Cape May Court House, NJ 08210 Phone: 609-465-2000 | |
Mark Robert Sorensen, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 211 S Main St, Suite 205, Cape May Court House, NJ 08210 Phone: 609-463-0800 Fax: 609-463-0957 | |
Sahil R Shaikh, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2 Stone Harbor Blvd, Cape May Court House, NJ 08210 Phone: 609-463-2803 Fax: 609-463-4991 | |
Dr. Holli Ami Barth, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2 Stone Harbor Blvd, Cape May Court House, NJ 08210 Phone: 609-463-2498 | |
Michael N Boriss, DO Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 217 N Main St, Suite 205, Cape May Court House, NJ 08210 Phone: 609-463-2755 Fax: 609-463-2757 | |
Dr. Suketu H Nanavati, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2 Village Dr, Cape May Court House, NJ 08210 Phone: 609-465-7517 |